/////

Charge Enterprises, Inc.

(Formerly TransWorld Holdings, Inc.

And GoIP Global, Inc.)

and Subsidiaries

CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended

September 30, 2021

CHARGE ENTERPRISES, INC.

(FORMERLY TRANSWORLD HOLDINGS, INC. AND GOIP GLOBAL, INC.)

AND SUBSIDIARIES

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Consolidated Financial Statements

Consolidated Balance Sheets at September 30, 2021 (Unaudited) and December 31, 2020

F-1

Consolidated Statements of Operations (Unaudited) for the Three and Nine months ended September 30, 2021 and

F-2

2020

Consolidated Statements of Comprehensive Loss (unaudited) for the Nine months ended September 30, 2021 and

F-3

2020

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) for the Nine months ended September 30,

F-4-F-5

2021 and 2020

Consolidated Statements of Cash Flows (Unaudited) for the Nine months ended September 30, 2021 and 2020

F-6

Notes to Unaudited Consolidated Financial Statements

F-7

-1-

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and

Stockholders of Charge Enterprises, Inc.

Results of Review of Interim Financial Information

We have reviewed the consolidated balance sheets of Charge Enterprises, Inc. and subsidiary (the Company) as of September 30, 2021, and the related consolidated statements of operations, comprehensive income (loss), and stockholders equity and cash flows for the nine-months ended September 30, 2021 and 2020, and the related notes (collectively referred to as the interim consolidated financial statements). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim consolidated financial statements for them to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)(PCAOB), the balance sheet of the Company at December 31, 2020, and the related statements of operations, comprehensive income (loss), changes in stockholders' equity and cash flows for the year the ended (not presented herein); and in our report dated July 13, 2021 (except for note 5 as to which the date is August 12, 2021), we expressed an unqualified opinion on those financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of December 31, 2020, is fairly stated, in all material respects, in relation to the balance sheet from which it has been derived.

Basis for Review Results

These interim consolidated financial statements are the responsibility of the Company's management. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

s Seligson & Giannattasio, LLP

Seligson & Giannattasio, LLP White Plains, New York November 18, 2021

CHARGE ENTERPRISES, INC.

(FORMERLY TRANSWORLD HOLDINGS, INC. AND GOIP GLOBAL, INC.) AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

September 30,

December 31,

2021 (Unaudited)

2020

ASSETS

Current assets:

Cash and cash equivalents

$

9,425,732

$

11,629,303

Accounts receivable, net

52,112,088

64,129,327

Inventory

156,641

-

Deposits and prepaids

625,818

370,081

Other current assets net

466,186

227,307

Investment in marketable securities

12,829,125

3,249,710

Investment in non-marketable securities

100,000

149,262

Accrued revenue

3,337,534

-

Total current assets

79,053,124

79,754,990

Property, plant and equipment, net

1,960,607

1,774,176

Capital lease asset

318,604

-

Right-of-use asset

550,098

-

Non-current assets

-

259,157

Goodwill

14,190,301

17,175,990

Deferred tax asset

6,344,895

443,006

Total assets

$

102,417,629

$

99,407,319

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

63,764,064

$

69,914,181

Accrued liabilities

2,485,380

785,172

Deferred revenue

62,973

3,455,886

Convertible notes payable, net of discount

2,849,149

1,436,144

Convertible notes payable, related parties, net of discount

-

275,984

Line of credit

1,514,476

-

Related party payable

-

189,312

Derivative liabilities

-

749,600

Capital lease liability

246,808

-

Lease liability

154,639

-

Total current liabilities

71,077,489

76,806,279

Non-current liabilities:

Lease liability, non-current

379,552

-

Notes payable, net of discount

10,252,039

-

Convertible notes payable, net of discount

3,920,346

1,947,945

Total liabilities

85,629,426

78,754,224

Mezzanine Equity

Series B (See Note 15) Preferred Stock

6,850,000

-

Commitments and contingencies

Stockholder's Equity

Preferred stock, $0.001 par value, 10,000,000 shares authorized;

Series A: 1,000,000 shares issued and outstanding at September 30, 2021 and

December 31, 2020

1,000

1,000

Common stock, $0.001 par value; 6,800,000,000 shares authorized 152,226,323 and

140,018,383 issued and outstanding at September 30, 2021 and December 31, 2020

152,301

140,018

Common stock to be issued, 6,587,897 and 13,425,750 shares at September 30, 2021 and

December 31, 2020

6,589

13,426

Treasury stock

(76)

Additional paid in capital

98,844,657

72,583,222

Accumulated other comprehensive income (loss)

(27,648)

60,375

Accumulated deficit

(89,038,620)

(52,144,946)

Total stockholders' equity

9,938,203

20,653,095

Total liabilities and stockholders' equity

$

102,417,629

$

99,407,319

The accompanying notes are an integral part of these consolidated financial statements.

F-1

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Clenergen Corp. published this content on 18 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 November 2021 21:22:05 UTC.